FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.05-5504fje.
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.05-5504fjev1
20/9/1513    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, L.
Right arrow Articles by Xu, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, L.
Right arrow Articles by Xu, X.
(The FASEB Journal. 2006;20:1513-1515.)
© 2006 FASEB

C terminus of RGS-GAIP-interacting protein conveys neuropilin-1-mediated signaling during angiogenesis

Ling Wang*,{dagger}, Debabrata Mukhopadhyay{dagger},1,2 and Xiaolei Xu*,1,2


* Department of Biochemistry and Molecular Biology,

{dagger} Mayo Clinic Cancer Center, Mayo Clinic College of Medicine, Rochester, Minnesota, USA

1 Correspondence: D.M., Department Biochemistry and Molecular Biology, Gugg 1401A, Mayo Clinic College of Medicine, 200 First St. SW, Rochester, MN 55905, USA. E-mail: mukhopadhyay.debabrata{at}mayo.edu; X. X., Department Biochemistry and Molecular Biology, Gugg 1701C, Mayo Clinic College of Medicine, 200 First St. SW, Rochester, MN 55905, USA. E-mail: xu.xiaolei{at}mayo.edu

SPECIFIC AIMS

Neuropilin-1 (NRP-1) is one of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptors that is involved in normal vascular development as well as pathological angiogenesis, but the mechanism is unclear. Initially, it was thought that there was an absence of intracellular signaling by VPF/VEGF through NRP-1 alone. However, the emerging data from our group as well as others suggest that the signaling through NRP-1 actually promotes angiogenesis and is mediated through its C-terminal domain and downstream molecules such as phosphoinositide 3-kinase. Therefore, the aim of this work is to elucidate the signal pathways mediated by NRP-1 and identify its downstream molecules and its functional role in angiogenesis.

PRINCIPLE FINDINGS

1. C-terminal three amino acids of NRP-1 (SEA-COOH) is required for NRP-1-mediated zebrafish angiogenesis
C-terminal three amino acids of NRP-1 (SEA-COOH) are conserved from Xenopus to human, which suggests it might be a key functional domain for NRP-1 signaling. Since the in vivo process of angiogenesis in zebrafish has been well documented, we would like to investigate the functions of the C-terminal three amino acids (SEA-COOH) of NRP-1 in zebrafish. To confirm the functional importance of the C-terminal domain of NRP-1, as suggested by our in vitro studies, we injected hNRP-1{Delta}SEA mRNA, which deleted the C-terminal three amino acids (SEA-COOH) in human NRP-1, and analyzed its effects on zebrafish angiogenesis. In contrast to injection of full-length hNRP-1, coinjection of hNRP-1{Delta}SEA mRNA with zNRP-1 morpholinos cannot rescue the vascular-specific phenotypes of NRP-1 knockdown. On the contrary, we observed disastrous vessel defects in the formation of dorsal longitudinal anastomotic vessel (DLAV), intersegmental vessel (ISV), and subintestinal vein (SIV; Fig. 1 ), lack of blood flow in these vessels, and more significant reduction in body size. These data suggest that hNRP-1{Delta}SEA may function as a dominant negative mutant. Indeed, injection of hNRP-1{Delta}SEA alone disrupted the formation of DLAV, ISV, and SIV, which resembles the phenotypes generated from zNRP-1 knockdown (Fig. 1) . As expected, injection of hNRP-1 mRNA showed normal vessel development. Hence, our data further underscored the importance of the C-terminal three amino acids in the function of the NRP-1 as the signaling mediator during angiogenesis, especially during the migration event.


Figure 1
View larger version (34K):
[in this window]
[in a new window]
 
Figure 1. C-terminal three amino acids (SEA-COOH) of NRP-1 are key functional domains for NRP-1 signaling. A) C-terminal three amino acids (SEA-COOH) of NRP-1 are required for NRP mediated angiogenesis. Confocal images of 2 days and dpf TG(fli1:egfp) embryos. Dorsal is up and anterior is left. Upper three ranks reveal the phenotypes of morpholinos and mRNA treatment. Arrow indicates DLAV; brackets indicate ISV and SIV, respectively; and double arrowheads indicate DA and PCV. Lower rank shows immunoblotting result that reveals protein expression concentration of human hNRP-1{Delta}SEA or hNRP-1 in zebrafish. Lower panel) Percentage of vessel defect (n=60, 30, 85, and 120, at 0.1 ng hNRP-1{Delta}SEA, 0.3 ng hNRP-1{Delta}SEA, 0.1 ng hNRP-1, and 0.3 ng hNRP-1 injection groups, respectively).

2. C-terminal domain of NRP-1 interacts with RGS-GAIP-interacting protein C terminus in endothelial cells
It is expected that the C-terminal domain of NRP-1 couples with intracellular signaling molecules directly or through an adapter protein to convey its functions. As stated before, we hypothesized that NRP-1 transduces the signal in endothelial cells (ECs) through its C-terminal domain by interacting with C terminus of RGS-GAIP-interacting protein (GIPC). To test this hypothesis, we initially sought to confirm the protein-protein interaction between NRP-1 and GIPC in human umbilical vein endothelial cells (HUVECs). We characterized the expression of GIPC in HUVECs by using a polyclonal antibody against GIPC protein. By immunoprecipitation and immunoblotting, anti-GIPC antibody (Ab) detected a specific band with molecular masses {approx}40 kDa, which corresponds to the size of GIPC found in the nervous system (39 kDa). Meanwhile, a coimmunoprecipitation experiment was also performed to confirm the physical interaction between endogenous NRP-1 and GIPC. Moreover, when HUVEC cell lysates were immunoprecipitated with an anti-NRP-1 Ab followed by immunoblotting with anti-GIPC Ab, GIPC coimmunoprecipitated with NRP-1. Furthermore, we were able to show that the chimeric receptor of NRP-1, EGNP-1, could interact with GIPC, but deletion of the C-terminal three residues of NRP-1 (EGNP-1{Delta}SEA) abolished its interaction with GIPC, although the expression concentration of the truncated NRP-1 protein was comparable with the full-length construct. These observations confirm the specific interaction of NRP-1 with GIPC is mediated by its C-terminal three amino acids (SEA-COOH) in vascular endothelium.

3. GIPC expresses in zebrafish vasculature and is required for angiogenesis by involving in NRP-1-mediating EC migration
By searching the zebrafish genomic database, we identified genomic sequence of zebrafish NIP (zGIPC). The predicted amino acid of zGIPC is highly homologous (82% identity) to the human GIPC protein sequences (data not shown). The expression patterns of zGIPC during embryogenesis were characterized by whole mount in situ hybridization at 18-somite stage, 24 h postfertilization (hpf; zebrafish embryonic stages) and 48 hpf. In the embryos of 18-somite and 24 and 48 hpf, the expression of zGIPC was observed in the brain and probably the central nervous system, which is consistent with the previous finding in the mouse. Interestingly, the GIPC transcript was detected in embryo 18-somite stages in the trunk region; two bilateral stripes of GIPC-positive cells reached the tailed region and converged toward the ventral midline to merge into a single stripe and terminated at the ventral region of the tail (Fig. 2 A). These cells give rise to the ECs. Furthermore, we detected the expression of zGIPC in developing vessels including trunk vessels [dorsal aorta (DA) and posterior cardinal vein (PCV)] and caudal vein plexus (CVP) at 24 and 48 hpf embryos (Fig. 2A ). The transient expression pattern is consistent with those from NRP-1a and 1b. To analyze the function of zGIPC during zebrafish angiogenesis, we knocked down zGIPC expression using morpholino antisense oligoes. Injection of 1.25 ng zGIPC morpholino into TG(fli1:egfp) embryos disturbed the formation of DLAV and SIV. Injection of 10 ng zGIPC morpholino results in more severe vessel defects including DLAV, ISV, and SIV (Fig. 2B ). Circulation in DLAV and ISV was diminished or blocked. The body size was reduced as well. These phenotypes resemble those from NRP-1 knockdown, which suggests that zGIPC is involved in the NRP-1 signaling pathway. To address the functions of GIPC in NRP-1 signaling, we analyzed the role of GIPC in NRP-1/EGNP-1-mediated HUVEC migration. For this purpose, we first knocked down GIPC in the HUVECs by using RNA interference-mediated silencing and performed migration assays. Interestingly, after 2 h of incubation, EC migration induced by epidermal growth factor (EGF) in EGNP-1-transduced HUVEC increased {approx}2-fold than that of untransfected HUVECs or HUVECs transduced with LacZ. However, the transfection of HUVECs with GIPC siRNA significantly blocked EGNP-1-mediated HUVECs migration (P value is 0.0156, 0.0042, and 0.0014 in a Student’s t test, compare 0.03, 0.3, and 3 pM GIPC siRNA silencing groups with no silencing group, respectively, in EGNP-1 transduced HUVECs), whereas the control siRNA did not (P value is 0.0557 in a Student’s t test). HUVECs transduced by increasing amounts of GIPC siRNA progressively blocked migration of EC. Inconsistent with our in vivo data, these data further suggested that GIPC is involved in NRP-1-mediated EC migration.


Figure 2
View larger version (69K):
[in this window]
[in a new window]
 
Figure 2. GIPC involves angiogenesis. A) Expression of GIPC in zebrafish. Upper rank reveals the whole mount in situ hybridization of zGIPC in different stages of zebrafish embryos. Dorsal is up and anterior is left. Lower rank shows transverse section through the trunk of different stages of zebrafish embryos. Dorsal is up. Arrowheads depict zGIPC-expressing cells. B) GIPC is required for DLAV and SIV formation during zebrafish angiogenesis. Confocal images of 2 days postfertilization TG(fli1:egfp) embryos. Upper three ranks reveal phenotypes of morpholinos. Lower panel) Percentage of vessel defects (n=120 and 65 at 1.25 ng and 10 ng GIPC morpholion injection groups, respectively).

4. PDZ domain of GIPC is a key functional domain in GIPC-mediated NRP-1-induced angiogenesis
Furthermore, the role of the PDZ domain of GIPC in angiogenesis was explored in this study. Coinjection of hGIPC mRNA with zGIPC morpholino rescued the phenotype of zGIPC knockdown and thus displayed normal vessel and circulation. However, coinjection of hGIPC{Delta}PDZ mRNA with zGIPC morpholino did not rescue zGIPC knockdown phenotype despite similar levels of protein expression. Taken together, these results suggest that the PDZ domain of GIPC plays an important role in GIPC-mediated NRP-1-induced angiogenesis, probably by interacting with the C-terminal domain of NRP-1 (SEA-COOH).

CONCLUSIONS AND SIGNIFICANCE

This study showed for the first time that the C-terminal three amino acids of NRP-1 (SEA-COOH) are key functional domains for NRP-1-mediated angiogenesis. Moreover, this study identifies that the C-terminal three amino acids of NRP-1 (SEA-COOH) can interact with GIPC in ECs and reveals that GIPC can mediate the signaling steps necessary by its PDZ domain for NRP-1-mediated angiogenesis, especially EC migration event. These findings support our current model for NRP-1-mediated VPF/VEGF-induced angiogenesis (Fig. 3 ). Overall, this study provides more insights regarding the role of NRP-1 in vascular development and angiogenesis and, therefore, holds significant clinical applications for cancers, cardiovascular diseases, and neurological disorders.


Figure 3
View larger version (10K):
[in this window]
[in a new window]
 
Figure 3. Model of NRP-1-mediated VPF/vascular endothelial growth factor-induced angiogenesis

FOOTNOTES

2 These authors contributed equally to this work.

To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.05-5504fje




This article has been cited by other articles:


Home page
Cancer Res.Home page
Y. Cao, L. Wang, D. Nandy, Y. Zhang, A. Basu, D. Radisky, and D. Mukhopadhyay
Neuropilin-1 Upholds Dedifferentiation and Propagation Phenotypes of Renal Cell Carcinoma Cells by Activating Akt and Sonic Hedgehog Axes
Cancer Res., November 1, 2008; 68(21): 8667 - 8672.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Prahst, M. Heroult, A. A. Lanahan, N. Uziel, O. Kessler, N. Shraga-Heled, M. Simons, G. Neufeld, and H. G. Augustin
Neuropilin-1-VEGFR-2 Complexing Requires the PDZ-binding Domain of Neuropilin-1
J. Biol. Chem., September 12, 2008; 283(37): 25110 - 25114.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Salikhova, L. Wang, A. A. Lanahan, M. Liu, M. Simons, W. P. J. Leenders, D. Mukhopadhyay, and A. Horowitz
Vascular Endothelial Growth Factor and Semaphorin Induce Neuropilin-1 Endocytosis via Separate Pathways
Circ. Res., September 12, 2008; 103(6): e71 - e79.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. Cebe-Suarez, F. S. Grunewald, R. Jaussi, X. Li, L. Claesson-Welsh, D. Spillmann, A. A. Mercer, A. E. Prota, and K. Ballmer-Hofer
Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR
FASEB J, August 1, 2008; 22(8): 3078 - 3086.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Sulpice, J. Plouet, M. Berge, D. Allanic, G. Tobelem, and T. Merkulova-Rainon
Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity
Blood, February 15, 2008; 111(4): 2036 - 2045.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. H. Muders, S. K. Dutta, L. Wang, J. S. Lau, R. Bhattacharya, T. C. Smyrk, S. T. Chari, K. Datta, and D. Mukhopadhyay
Expression and Regulatory Role of GAIP-Interacting Protein GIPC in Pancreatic Adenocarcinoma
Cancer Res., November 1, 2006; 66(21): 10264 - 10268.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.05-5504fjev1
20/9/1513    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, L.
Right arrow Articles by Xu, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, L.
Right arrow Articles by Xu, X.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The Federation of American Societies for Experimental Biology.